Lialda® (mesalamine) – First-time generic
June 15, 2017 - The FDA approved Zydus’ AB-rated generic to Shire’s Lialda (mesalamine) 1.2 gram delayed-release tablets, indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis and for the maintenance of remission of ulcerative colitis.
Top